Table III.

Differentially expressed mRNA in the competing endogenous RNA network of lung adenocarcinoma.

mRNA	logFC	P-value	FDR
HOXC13	6.96	1.73×10−22	1.34×10−21
SALL1	5.81	6.30×10−17	3.21×10−16
HOXA10	4.22	4.90×10−22	3.67×10−21
NPTX1	3.76	4.78×10−16	2.26×10−15
PSAT1	3.52	3.76×10−48	1.06×10−46
ELAVL2	3.47	1.09×10−15	5.03×10−15
PBK	3.41	3.11×10−43	7.08×10−42
CCNE1	3.31	1.55×10−42	3.43×10−41
CEP55	3.28	1.30×10−55	5.03×10−54
SLC7A11	3.09	2.38×10−23	1.96×10−22
CCNB1	3.00	8.18×10−55	3.01×10−53
RET	2.97	1.80×10−13	6.93×10−13
COL1A1	2.91	9.49×10−32	1.27×10−30
E2F7	2.76	3.91×10−31	5.04×10−30
CLSPN	2.75	4.81×10−40	9.63×10−39
TBX18	2.69	2.39×10−10	7.10×10−10
KCNQ5	2.65	4.31×10−20	2.80×10−19
KIF23	2.61	6.02×10−43	1.35×10−41
CBX2	2.52	1.99×10−25	1.86×10−24
CDC25A	2.37	1.98×10−37	3.51×10−36
CHEK1	2.26	1.69×10−43	3.89×10−42
MCM4	2.24	4.41×10−47	1.17×10−45
COL5A2	2.20	5.53×10−28	6.09×10−27
PFKP	2.17	2.44×10−33	3.57×10−32
MIXL1	2.00	5.19×10−17	2.66×10−16
PROK2	−2.02	1.49×10−24	1.32×10−23
SLC1A1	−2.17	1.86×10−50	5.75×10−49
OSCAR	−2.20	3.65×10−67	2.25×10−65
BDNF	−2.31	2.27×10−32	3.15×10−31
TGFBR3	−2.53	1.67×10−87	1.77×10−85
SELE	−2.90	2.85×10−63	1.50×10−61
RS1	−3.70	1.04×10−94	1.30×10−92
TMEM100	−4.31	1.71×10−143	7.55×10−141
SERTM1	−4.74	3.04×10−70	2.05×10−68

FC, fold-change; FDR, false discovery rate.